Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)

Huaxia Eye Hospital Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Revenue	3,991	3,922	3,774	3,745	3,130	3,007
Other Revenue	217.37	217.37	253.24	268.34	103.09	57.77
Revenue	4,209	4,139	4,027	4,013	3,233	3,064
Revenue Growth	2.23%	2.79%	0.34%	24.12%	5.51%	21.86%
Cost of Revenue	2,409	2,356	2,259	2,055	1,687	1,661
Gross Profit	1,800	1,783	1,768	1,958	1,546	1,403
Selling, General & Admin	1,089	1,086	1,077	986.7	758.43	712.2
Research & Development	58.65	61.44	70.63	69.68	49.27	25.2
Other Operating Expenses	28.52	15.02	13.66	11.89	10.82	12.43
Operating Expenses	1,176	1,168	1,173	1,080	822.02	754.19
Operating Income	623.51	615.23	594.57	878.8	724.3	649.04
Interest Expense	-46.91	-46.96	-45.13	-38.04	-38.36	-37.61
Interest & Investment Income	27.55	52.22	87.6	99.96	19.2	10.47
Other Non Operating Income (Expenses)	18.15	-7.89	-86.73	-124.11	-78.25	-5.97
EBT Excluding Unusual Items	622.3	612.6	550.31	816.61	626.88	615.93
Impairment of Goodwill	-6.19	-6.19	-11.24	-4.64	-	-
Gain (Loss) on Sale of Investments	11.94	-9.29	-5.09	11.02	6.51	-
Gain (Loss) on Sale of Assets	5.39	2.46	3.49	11.28	1.85	0.1
Asset Writedown	-0.88	-1.42	-0.79	-1.51	-0.46	-1.88
Other Unusual Items	-3.23	-24.35	26.49	21.55	18.83	-31.82
Pretax Income	629.33	573.81	563.17	854.31	653.61	582.33
Income Tax Expense	158.87	140.76	134.95	176.89	144.41	128.7
Earnings From Continuing Operations	470.46	433.06	428.22	677.42	509.2	453.63
Net Income to Company	470.46	433.06	428.22	677.42	509.2	453.63
Minority Interest in Earnings	2.69	7.6	0.43	-11.49	4.62	1.29
Net Income	473.15	440.65	428.64	665.93	513.82	454.92
Net Income to Common	473.15	440.65	428.64	665.93	513.82	454.92
Net Income Growth	7.19%	2.80%	-35.63%	29.60%	12.95%	36.01%
Shares Outstanding (Basic)	842	831	840	843	767	750
Shares Outstanding (Diluted)	842	831	840	843	767	750
Shares Change	0.84%	-1.08%	-0.29%	9.92%	2.28%	0.14%
EPS (Basic)	0.56	0.53	0.51	0.79	0.67	0.61
EPS (Diluted)	0.56	0.53	0.51	0.79	0.67	0.61
EPS Growth	6.30%	3.92%	-35.44%	17.91%	10.43%	35.82%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	727.72	635.59	540.71	512.81	534.68	624.38
Free Cash Flow Per Share	0.86	0.76	0.64	0.61	0.70	0.83
Dividend Per Share	0.170	0.260	0.220	0.110	0.187	-
Dividend Growth	-45.16%	18.18%	100.00%	-41.08%	-	-
Gross Margin	42.76%	43.07%	43.90%	48.80%	47.83%	45.79%
Operating Margin	14.82%	14.86%	14.77%	21.90%	22.40%	21.18%
Profit Margin	11.24%	10.65%	10.64%	16.59%	15.89%	14.85%
Free Cash Flow Margin	17.29%	15.36%	13.43%	12.78%	16.54%	20.38%
EBITDA	787.15	781.48	764.3	1,028	878.91	803.7
EBITDA Margin	18.70%	18.88%	18.98%	25.60%	27.18%	26.23%
D&A For EBITDA	163.64	166.25	169.73	148.75	154.61	154.66
EBIT	623.51	615.23	594.57	878.8	724.3	649.04
EBIT Margin	14.82%	14.86%	14.77%	21.90%	22.40%	21.18%
Effective Tax Rate	25.24%	24.53%	23.96%	20.71%	22.10%	22.10%
Revenue as Reported	4,209	4,139	4,027	4,013	3,233	3,064
Advertising Expenses	-	271.14	273.11	259.35	147.9	129.24

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error